Good results on Teva's lab-made antibody that blocks gluten damage raise hopes that a treatment for celiac disease may ...

This article explores how advances in antibody engineering are moving immunotherapy beyond traditional monoclonal antibodies to bispecific and trispecific formats and logic-gated designs.

AI antibody discovery can be accelerated by integrating computational prediction with experimental production, validation, ...

VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine, demonstrating VYD2311 safety and ...

As the election cycle heats up, the debate over Medicare and the implications of single-payer healthcare resurfaces, raising ...

Recently, the 'Key Rules for Inter-provincial Joint Procurement of Monoclonal Antibody Drugs Led by Anhui Province (Draft for Comments)' has been circulating within the industry. This proposal ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, ...

We have focused on regulatory advancement of our broad spectrum antiviral drug NV- 387. We received approval for Phase II clinical trial to evaluate the safety and efficacy of NV-387 Oral Gummies for ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough ...

Alberta is now offering free RSV immunizations for all babies born in hospital during the fall respiratory virus season, following calls from pediatricians to provide the preventative vaccine ...

Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today the signing of an exclusive distribution agreement with Kyowa Kirin International (“KKI”) ...

An analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the world found that viral variants ...